injectable drugs

WuXi STA Opens new Parenteral Formulation Line

WuXi STA has started up a new parenteral formulation line at its drug product site in Wuxi City, China. The company’s second line for parenteral drug product clinical and commercial manufacturing to go on stream this year has an annual capacity of 10 million units.

Pfizer Gets Green Light for Hospira Acquisition

Fresenius May Lift Outlook Again on Rivals' Shortages

U.S. Health Advisers Back Two New Eye Treatments

Small Generic Drug Firms Need Niches to Survive Looming Price War

Top-Feature

Aenova Holding GmbH

Aseptic processing by design: The flexible and efficient use of RABS and Isolators

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship